Skip to main content
. 2023 Oct 6;67(11):e00440-23. doi: 10.1128/aac.00440-23

TABLE 2.

MICs of meropenem and cefepime alone and in combination with BLIs against the panel of engineered P. aeruginosa strains producing various cloned β-lactamases

Strain Β-lactamΒ-lactamase Class MEM MEM + XER MEMP + VAB MEM + AVI MEM + REL MEM + TAN MEM + DUR FEP FEP + XER FEP + VAB FEP + AVI FEP + REL FEP + TAN FEP + DUR
PAM4175 none 0.125 a ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 0.25 0.125 0.25 0.125 0.25 0.125 ≤0.06
PAM4743 CTX-M-15 A 0.25 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 >64 0.125 1 0.125 1 0.25 0.125
PAM4821 CTX-M-25 A 0.5 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 0.125 >64 0.125 4 0.25 1 0.25 0.125
PAM4823 CTX-M-27 A 0.5 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 >64 0.125 2 0.25 2 0.25 0.125
PAM4800 GES-19 A 1 ≤0.06 0.125 ≤0.06 0.125 ≤0.06 ≤0.06 64 0.125 1 0.25 0.5 0.125 ≤0.06
PAM4801 GES-20 A 8 ≤0.06 0.25 ≤0.06 0.25 ≤0.06 ≤0.06 2 0.125 0.25 0.25 0.25 0.25 ≤0.06
PAM4135 KPC-2 A 32 ≤0.06 ≤0.06 ≤0.06 0.125 ≤0.06 ≤0.06 >64 0.125 0.25 0.25 0.25 0.25 0.125
PAM4689 KPC-3 A 64 ≤0.06 ≤0.06 ≤0.06 0.125 ≤0.06 ≤0.06 >64 0.125 0.25 0.25 0.5 0.25 0.25
PAM4825 MIR-1 C 0.5 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ND 2 ≤0.06 0.125 0.125 0.125 0.125 ND
PAM4840 OXY-6–2 A 0.25 ≤0.06 0.125 ≤0.06 ≤0.06 ≤0.06 ≤0.06 8 0.125 4 0.25 0.25 0.25 0.125
PAM4842 PER-2 A 0.125 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 64 0.125 0.5 0.25 0.25 0.125 ≤0.06
PAM4907 PER-4 A 0.125 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 64 0.125 16 32 32 0.5 0.5
PAM4874 SHV-12 A 0.25 ≤0.06 0.125 ≤0.06 ≤0.06 ≤0.06 ≤0.06 64 0.125 4 0.25 1 0.25 ≤0.06
PAM4744 SME-2 A 8 ≤0.06 ≤0.06 ≤0.06 0.25 ≤0.06 0.125 0.5 ≤0.06 0.125 0.125 0.125 0.25 0.125
PAM4878 TEM-10 A 0.125 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 16 ≤0.06 2 0.125 0.25 0.25 ≤0.06
PAM4908 VEB-1 A 0.5 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 >64 0.125 2 0.25 0.25 0.25 ≤0.06
PAM4910 VEB-2 A 0.25 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 >64 0.125 4 0.25 0.5 0.5 ≤0.06
PAM4186 CMY-2 C 0.25 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ND 1 ≤0.06 0.125 ≤0.06 ≤0.06 ≤0.06 ND
PAM4745 P99 C 1 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 0.125 8 0.125 0.25 0.125 0.125 0.125 ≤0.06
PAM4869 PDC-1 C 0.5 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 4 0.125 0.5 0.25 0.125 0.125 0.125
PAM4884 ADC-181 C 0.125 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ND 0.5 ≤0.06 0.25 ≤0.06 ≤0.06 0.125 ND
PAM4827 OXA-1 D ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 1 ≤0.06 1 ≤0.06 0.25 0.25 ≤0.06
PAM4792 OXA-2 D 2 ≤0.06 2 0.5 0.5 ≤0.06 0.125 0.5 ≤0.06 0.5 0.125 0.125 0.125 ≤0.06
PAM4846 OXA-9 D 0.25 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 ≤0.06 2 0.125 0.25 0.125 1 0.125 0.125
PAM4217 OXA-48 D 4 ≤0.06 4 ≤0.06 2 0.125 0.125 0.5 0.125 0.5 0.125 0.25 0.125 0.125
PAM4875 OXA-23 D 2 ≤0.06 2 0.5 2 2 ≤0.06 2 ≤0.06 2 0.25 1 1 ≤0.06
PAM4876 OXA-72 D 2 ≤0.06 2 0.5 2 2 ≤0.06 2 ≤0.06 2 0.25 1 1 ≤0.06
PAM4179 NDM-1 B 32 2 32 32 32 2 16 >64 4 >64 >64 >64 8 >64
PAM4917 NDM-7 B 32 1 32 32 32 1 16 >64 2 >64 >64 >64 4 >64
PAM4795 VIM-1 B 4 ≤0.06 4 4 4 ≤0.06 4 >64 0.25 >64 >64 64 0.5 64
PAM4798 VIM-2 B 8 ≤0.06 8 8 4 ≤0.06 8 8 0.125 8 8 8 0.125 4
PAM4887 IMP-1 B 4 0.5 4 4 4 4 4 64 1 64 64 64 32 32
PAM4888 IMP-4 B 4 0.5 4 2 4 2 2 32 1 32 32 32 32 8
PAM4196 IMP-13 B 1 0.5 1 1 1 1 ND 16 1 16 16 16 16 ND
PAM4198 IMP-15 B 1 0.125 1 1 1 1 ND 16 0.5 16 16 16 16 ND
PAM4890 IMP-19 B 1 0.25 1 1 1 1 0.5 64 2 32 32 32 32 16
PAM4889 IMP-26 B 8 2 8 8 8 8 4 64 8 64 64 64 64 32
PAM4883 GIM-1 B 32 0.5 16 32 16 0.5 ND 8 0.25 8 8 8 0.125 ND
PAM4885 SPM-1 B 32 16 32 32 32 0.5 16 >64 64 >64 >64 >64 2 64
PAM4879 CcrA B 2 ≤0.06 2 2 2 1 ND 16 0.125 16 16 16 8 ND
PAM4880 L1 B 32 16 32 32 32 32 16 4 1 4 4 4 4 1
a

MICs for antibiotics alone and MICs of antibiotics with of BLIs that less than 4-fold lower than that of antibiotics alone are in boldfaced values.